Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Swiss imaging and lab groups sigh with relief

A new outpatient tariff which would have taken 6-10% points off imaging prices has been kicked down the road for the third time by the byzantine Swiss healthcare system. It would have severely clipped the very high margins enjoyed by many whilst upping prices for primary care.
June 9, 2022

Interview, Philippe Salah, CEO Dental Monitoring

Philippe Salah tells HBI he likes to keep a low profile. His success with remote dental care group DentalMonitoring, which reached elusive $1bn unicorn status at the end of last year, is making that increasingly difficult. HBI chats to him to find out more about his business model, and his vision of the dental clinic of the future.
June 9, 2022

Rutherford Health to go into liquidation

The for-profit oncology group which holds roughly half the UK's proton beam capacity and has invested over £240m in capex is to go into liquidation, thanks to the pandemic and NHS indifference. In the UK just 1% of acute cancer patients get proton compared to 10% in Europe and 20% in the USA. What is likely to happen next?
June 6, 2022

FREE BLOG Ever decreasing primary care circles

In many countries, getting to see a GP is no easy feat. In a British Social Attitudes survey in 2020, around 51% of people agreed that "it was hard to get an appointment with a GP".
June 1, 2022

Adoption and drivers of Digital Health Platforms by insurers

This week our infographic shows some of the key findings from the Digital Health Engagement Institute’s (DHEI) survey around the adoption and drivers of Digital Health Engagement Platforms (DHE Platforms) in the life and health insurance industry.
June 1, 2022

Nigeria approves new health insurance law

Nigeria's new health insurance law will set up a fund to cover the most vulnerable citizens in Africa's most populous country who might otherwise struggle to get medical care.
June 1, 2022

Interview Nick West, Chief Medical Officer, Global Medical Affairs, Abbott Vascular 

Patients, particularly in Europe, the Middle East and Africa, have a very different view of how well their treatment went than the physicians who treat them and health care leaders who oversee healthcare delivery. Patients are frustrated from the earliest stages of their care journey, including symptom recognition and definitive disease diagnosis. We talk to Dr. Nick West, the Chief Medical Officer, Global Medical Affairs for Abbott’s Vascular business about the results from Beyond Intervention - a multi-year global research initiative that uncovers the differing perspectives of the patient, the physician, and the healthcare leader.
May 27, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us